Maria D'apolito
Melito Di Porto Salvo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Do age and performance status matter? A systematic review and network meta-analysis of immunotherapy studies in untreated advanced/metastatic non-oncogene addicted NSCLC.
Journal: Frontiers in immunology
Published: May 25, 2025
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients.
Journal: Basic research in cardiology
Published: May 22, 2024
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology.
Journal: Journal of translational medicine
Published: September 16, 2022
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.
Journal: Molecular therapy. Nucleic acids
Published: March 14, 2022
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.
Journal: ESMO open
Published: November 19, 2021
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report.
Journal: Therapeutic advances in chronic disease
Published: May 15, 2021
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report.
Journal: Frontiers in oncology
Published: July 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026